Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04984590 · ClinicalTrials.gov registry record
Early Feasibility Study Using IOPCL MAG to Improve Near Vision in ARMD Subjects
A clinical trial of Age-related Macular Degeneration and Low Vision, sponsored by OnPoint Vision.
- Completed
- Registry status
- 9
- Enrollment target
- 1
- Study location
NCT04984590 is a study of Age-related Macular Degeneration and Low Vision that has completed, run by OnPoint Vision. The registered enrollment target is 9 participants, below the 1,508-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04984590, a study of Age-related Macular Degeneration and Low Vision, has completed, sponsored by OnPoint Vision.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
This early feasibility study aims to improve near vision in subjects 55 years or older who have a clinical diagnosis of Age-Related Macular Degeneration. Subjects must have previously been implanted with either the Alcon Model SN60WF or Model SA60AT intraocular lens at least 6-months prior to receiving the IOPCL (intraocular pseudophakic capsular lens). Subject will be followed for a period of 12-months.
Conditions Studied
Interventions
- DEVICE IOPCL AMD MAG
Study Locations (1)
California
- Harvard Eye Associates - Laguna Hills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2022-01-21 |
| Est. Completion | 2024-03-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04984590
The ClinicalTrials.gov registry entry for NCT04984590 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,508-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (99% lower). The listed sponsor is OnPoint Vision, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Age-related Macular Degeneration appearing as the primary indexed condition, and to 1 intervention - of which IOPCL AMD MAG is the first listed.
NCT04984590 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04984590 about?
NCT04984590 is a clinical study titled "Early Feasibility Study Using IOPCL MAG to Improve Near Vision in ARMD Subjects". This early feasibility study aims to improve near vision in subjects 55 years or older who have a clinical diagnosis of Age-Related Macular Degeneration. Subjects must have previously been implanted with either the Alcon Model SN60WF or Model SA60AT intraocular lens at least 6-months prior to receiv...
What is the current status of trial NCT04984590?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2022-01-21. Estimated completion is 2024-03-20.
What conditions does trial NCT04984590 study?
This clinical trial studies the following conditions: Age-related Macular Degeneration, Low Vision.
What interventions are being tested in trial NCT04984590?
The interventions under investigation include: IOPCL AMD MAG (DEVICE).
Who is sponsoring clinical trial NCT04984590?
This trial is sponsored by OnPoint Vision, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04984590 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-related Macular Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
RECRUITING · Phase 2
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
High Resolution Retinal Imaging
RECRUITING
-
Visual Remapping to Aid Reading With Field Loss
RECRUITING · NA
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RECRUITING · Phase 1
-
Effects of Goji vs. Fiber on Macular Degeneration
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.